Daniel P. van Plew, EVP & General Mgr, Industrial at REGENERON PHARMACEUTICALS, INC. (REGN), sold 61,971 shares at $735.57 ($45.9M) on 2022-11-23, disclosed to the SEC on 2022-11-25.
Open-market sale of $45.9M REGN by EVP & General Mgr, Industrial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $741.81 | 38,028 | $28.2M | 61.4% |
| 2 | $735.57 | 686 | $505K | 1.1% |
| 3 | $735.57 | 686 | $505K | 1.1% |
| 4 | $736.46 | 1,005 | $740K | 1.6% |
| 5 | $736.46 | 1,005 | $740K | 1.6% |
| 6 | $737.37 | 373 |
| $275K |
| 0.6% |
| 7 | $737.37 | 373 | $275K | 0.6% |
| 8 | $738.57 | 944 | $697K | 1.5% |
| 9 | $738.57 | 944 | $697K | 1.5% |
| 10 | $739.48 | 3,124 | $2.3M | 5.0% |
| 11 | $739.48 | 3,124 | $2.3M | 5.0% |
| 12 | $740.29 | 1,808 | $1.3M | 2.9% |
| 13 | $740.29 | 1,808 | $1.3M | 2.9% |
| 14 | $741.34 | 1,002 | $743K | 1.6% |
| 15 | $741.34 | 1,002 | $743K | 1.6% |
| 16 | $742.58 | 99 | $74K | 0.2% |
| 17 | $742.58 | 99 | $74K | 0.2% |
| 18 | $743.66 | 101 | $75K | 0.2% |
| 19 | $743.66 | 101 | $75K | 0.2% |
| 20 | $744.56 | 780 | $581K | 1.3% |
| 21 | $744.56 | 780 | $581K | 1.3% |
| 22 | $745.56 | 256 | $191K | 0.4% |
| 23 | $745.56 | 256 | $191K | 0.4% |
| 24 | $746.42 | 1,164 | $869K | 1.9% |
| 25 | $746.42 | 1,164 | $869K | 1.9% |
| 26 | $747.28 | 629 | $470K | 1.0% |
| 27 | $747.28 | 629 | $470K | 1.0% |
| 28 | $748.17 | 1 | $748 | 0.0% |
| Total | $741.40 avg | 61,971 | $45.9M | 100% |
| Filing → |
| REGN | SELL | 2022-11-08 | $10.9M | — | Filing → |
| REGN | SELL | 2022-09-13 | $6.7M | — | Filing → |
| REGN | SELL | 2022-02-24 | $6.4M | — | Filing → |